Fear Not the Fungus Treatment - Frankly Speaking EP 122

Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-113-deprescribing Overview: Since their arrival, oral anti-fungal agents have been thought to induce liver disease. Often, these medications are avoided or used with caution and frequent laboratory testing. Join us in a discussion of a recent study that builds on previous work showing the risk with using these agents is extremely small. Guest: Susan Feeney, DNP, FNP Landing Page: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-122

Episode metadata supplied by the publisher feed · Published May 27, 2019

Embed this episode

Attribution link and audio player

NOW PLAYING

Fear Not the Fungus Treatment - Frankly Speaking EP 122

0:00 10:37

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Pri-Med Podcasts?

This episode is 10 minutes long.

When was this Pri-Med Podcasts episode published?

This episode was published on May 27, 2019.

Can I download this Pri-Med Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!